Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine
Liu et al. describe the antibiotic adjuvant effect of the FDA approved drug, benzydamine, for the treatment of infections caused by multidrug-resistant bacteria. Mechanistically, benzydamine dissipates membrane potential in both Gram-positive and Gram-negative bacteria, upregulates the transmembrane...
Guardado en:
Autores principales: | Yuan Liu, Ziwen Tong, Jingru Shi, Yuqian Jia, Tian Deng, Zhiqiang Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b267cd9c901347399769c556a2740cfb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dissemination of antibiotic resistance genes from antibiotic producers to pathogens
por: Xinglin Jiang, et al.
Publicado: (2017) -
Persistence and reversal of plasmid-mediated antibiotic resistance
por: Allison J. Lopatkin, et al.
Publicado: (2017) -
Comparative transcriptomics of multidrug-resistant Acinetobacter baumannii in response to antibiotic treatments
por: Hao Qin, et al.
Publicado: (2018) -
DYNAMICS OF ANTIBIOTIC RESISTANCE OF NOSOCOMIAL PATHOGENS AND STATE OF ANTIBIOTiC THERAPY IN MULTIFIELD CLINIC
por: S. A. Vereshchagina, et al.
Publicado: (2012) -
IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria
por: Su Jin Lee, et al.
Publicado: (2021)